Topical Nonsteroidal Anti-Inflammatory Drugs for Osteoarthritis

References

• . Centers for Disease Control and Prevention. Prevalence of self-reported arthritis or chronic joint symptoms among adults—United States, 2001. MMWR Wkly. 2002;51(42):948–950
   PubMedGoogle Scholar
• . Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol. 2006;20(1):3–25
   PubMed Web of Science ®Google Scholar
• . Consumer Health Sciences. The Osteoarthritis Market: US Core Therapeutic Report. Princeton, NJ: Consumer Health Sciences; 2008
   Google Scholar
• . Hippisley-Cox J, Coupland C, Logan R. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ. 2005;331(7528):1310–1316
   PubMed Web of Science ®Google Scholar
• . Richy F, Bruyere O, Ethgen O, . Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach. Ann Rheum Dis. 2004;63(7):759–766
   PubMed Web of Science ®Google Scholar
• . Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ. 2005;330(7504):1366
   PubMed Web of Science ®Google Scholar
• . Whelton A, Hamilton CW. Nonsteroidal anti-inflammatory drugs: effects on kidney function. J Clin Pharmacol. 1991;31(7):588–598
   PubMed Web of Science ®Google Scholar
• . Huerta C, Castellsague J, Varas-Lorenzo C, García Rodríguez LA. Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis. 2005;45(3):531–539
   PubMed Web of Science ®Google Scholar
• . American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009;57(8):1331–1346
   PubMed Web of Science ®Google Scholar
• . National Collaborating Centre for Chronic Conditions. Osteoarthritis: The Care and Management of Osteoarthritis in Adults. London, UK: Royal College of Physicians; 2008
   Google Scholar
• . Mason L, Moore RA, Edwards JE, McQuay HJ, Derry S, Wiffen PJ. Systematic review of efficacy of topical rubefacients containing salicylates for the treatment of acute and chronic pain. BMJ. 2004;328(7446):995
   PubMed Web of Science ®Google Scholar
• . Furst DE. Are there differences among nonsteroidal anti-inflammatory drugs? Comparing acetylated salicylates, nonacetylated salicylates, and nonacetylated nonsteroidal anti-inflammatory drugs. Arthritis Rheum. 1994;37(1):1–9
   PubMedGoogle Scholar
• . Cordero JA, Camacho M, Obach R, Domenech J, Vila L. In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs. Eur J Pharm Biopharm. 2001;51(2):135–142
   PubMed Web of Science ®Google Scholar
• . Rao P, Knaus EE. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci. 2008;11(2):81s–110s
   PubMed Web of Science ®Google Scholar
• . Kienzler J, Gold M, Nollevaux F. Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers. J Clin Pharmacol New Drugs. 2010;50(1):50–61
   Google Scholar
• . Reilly IA, FitzGerald GA. Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs. Blood. 1987;69(1):180–186
   PubMed Web of Science ®Google Scholar
• . Barthel HR, Haselwood D, Longley S 3rd, Gold MS, Altman RD. Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis. Semin Arthritis Rheum. 2009;39(3):203–212
   PubMed Web of Science ®Google Scholar
• . Gondalf-Zink B, Gronwald U. Active substance concentration in articular and periarticular tissues of the knee joint after cutaneous application of diclofenac-diethylammonium emulgel. Akt Rheumatol. 1996;21:298–304
   Web of Science ®Google Scholar
• . Riess W, Schmid K, Botta L, . The percutaneous absorption of diclofenac. Arzneimittelforschung. 1986;36(7):1092–1096
   PubMed Web of Science ®Google Scholar
• . Rother M, Lavins BJ, Kneer W, Lehnhardt K, Seidel EJ, Mazgareanu S. Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomized controlled trial. Ann Rheum Dis. 2007;66(9):1178–1183
   PubMed Web of Science ®Google Scholar
• . Bruhlmann P, de Vathaire F, Dreiser RL, Michel BA. Short-term treatment with topical diclofenac epolamine plaster in patients with symptomatic knee osteoarthritis: pooled analysis of two randomized clinical studies. Curr Med Res Opin. 2006;22(12):2429–2438
   PubMed Web of Science ®Google Scholar
• . Baraf HS, Gold MS, Clark MB, Altman RD. Safety and efficacy of topical diclofenac sodium 1% gel in knee osteoarthritis: a randomized controlled trial. Phys Sportsmed. 2010;38(2):19–28
   PubMed Web of Science ®Google Scholar
• . Niethard FU, Gold MS, Solomon GS, . Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. J Rheumatol. 2005;32(12):2384–2392
   PubMed Web of Science ®Google Scholar
• . Grace D, Rogers J, Skeith K, Anderson K. Topical diclofenac versus placebo: a double blind, randomized clinical trial in patients with osteoarthritis of the knee. J Rheumatol. 1999;26(12):2659–2663
   PubMed Web of Science ®Google Scholar
• . Baer PA, Thomas LM, Shainhouse Z. Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomized controlled, 6-week trial [ISRCTN53366886]. BMC Musculoskelet Disord. 2005;6:44
   PubMed Web of Science ®Google Scholar
• . Roth SH, Shainhouse JZ. Efficacy and safety of a topical diclofenac solution (Pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial. Arch Intern Med. 2004;164(18):2017–2023
   PubMedGoogle Scholar
• . Simon LS, Grierson LM, Naseer Z, Bookman AA, Zev Shainhouse J. Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain. 2009;143(3):238–245
   PubMed Web of Science ®Google Scholar
• . Tugwell PS, Wells GA, Shainhouse JZ. Equivalence study of a topical diclofenac solution (Pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol. 2004;31(10):2002–2012
   PubMed Web of Science ®Google Scholar
• . Cross PL, Ashby D, Harding G, . TOIB Study Team. TOIB Study. Are topical or oral ibuprofen equally effective for the treatment of chronic knee pain presenting in primary care: a randomized controlled trial with patient preference study. [ISRCTN79353052]. BMC Musculoskelet Disord. 2005;6:55
   PubMedGoogle Scholar
• . Kozanoglu E, Basaran S, Guzel R, Guler-Uysal F. Short term efficacy of ibuprofen phonophoresis versus continuous ultrasound therapy in knee osteoarthritis. Swiss Med Wkly. 2003;133(23–24):333–338
   PubMed Web of Science ®Google Scholar
• . Trnavsky K, Fischer M, Vogtle-Junkert U, Schreyger F. Efficacy and safety of 5% ibuprofen cream treatment in knee osteoarthritis. Results of a randomized, double-blind, placebo-controlled study. J Rheumatol. 2004;31(3):565–572
   PubMed Web of Science ®Google Scholar
• . Underwood M, Ashby D, Carnes D, . Topical or oral ibuprofen for chronic knee pain in older people. The TOIB study. Health Technol Assess. 2008;12(22):iii–iv
   PubMedGoogle Scholar
• . Altman RD, Dreiser RL, Fisher CL, Chase WF, Dreher DS, Zacher J. Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. J Rheumatol. 2009;36(9):1991–1999
   PubMed Web of Science ®Google Scholar
• . Zacher J, Burger K, Farber L, . Topical diclofenac Emulgel versus oral ibuprofen in the treatment of active osteoarthritis of the finger joints (Heberden's and/or Bouchard's nodes). Double-blind, controlled, randomized study. Aktuel Rheumatology. 2001;26:7–14
   Web of Science ®Google Scholar
• . Widrig R, Suter A, Saller R, Melzer J. Choosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomized, double-blind study. Rheumatol Int. 2007;27(6):585–591
   PubMed Web of Science ®Google Scholar
• . Zhang W, Nuki G, Moskowitz RW, . OARSI recommendations for the management of hip and knee osteoarthritis, part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010;18(4):476–499
   PubMed Web of Science ®Google Scholar
• . Tubach F, Ravaud P, Baron G, . Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis. 2005;64(1):29–33
   PubMed Web of Science ®Google Scholar
• . Barthel HR, Peniston JH, Clark MB, Gold MS, Altman RD. Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis. Arthritis Res Ther. 2010;12(1):R7
   Google Scholar
• . Singh G, Fort JG, Goldstein JL, ; SUCCESS-I Investigators.Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. Am J Med. 2006;119(3):255–266
   PubMed Web of Science ®Google Scholar
• . Niculescu L, Li C, Huang J, Mallen S. Pooled analysis of GI tolerability of 21 randomized controlled trials of celecoxib and nonselective NSAIDs. Curr Med Res Opin. 2009;25(3):729–740
   PubMed Web of Science ®Google Scholar
• . Moore RA, Derry S, Makinson GT, McQuay HJ. Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports. Arthritis Res Ther. 2005;7(3):R644–R665
   PubMed Web of Science ®Google Scholar
• . Gloth FM, Petruschke RA, Gold MS, Wieman MS. Safety and efficacy of diclofenac sodium 1% gel for knee osteoarthritis in patients with comorbidities. Poster presented at: American Pain Society Annual Scientific Meeting; May 6–8, 2010; Baltimore, MD
   Google Scholar
• . Voltaren® Gel 1% (diclofenac sodium topical gel) [package insert]. Parsippany, NJ: Novartis Consumer Health, Inc; 2009
   Google Scholar
• . PENNSAID® (diclofenac sodium topical solution) [package insert]. Varennes, Quebec, Canada: Nuvo Manufacturing; 2010
   Google Scholar
• . Sandelin J, Harilainen A, Crone H, Hamberg P, Forsskahl B, Tamelander G. Local NSAID gel (eltenac) in the treatment of osteoarthritis of the knee. A double blind study comparing eltenac with oral diclofenac and placebo gel. Scand J Rheumatol. 1997;26(4):287–292
   PubMed Web of Science ®Google Scholar
• . Dickson DJ. A double-blind evaluation of topical piroxicam gel with oral ibuprofen in osteoarthritis of the knee. Curr Ther Res Clin Exp. 1991;49(2):199–207
   Web of Science ®Google Scholar
• . Zhang W, Doherty M, Leeb BF, . EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007;66(3):377–388
   PubMed Web of Science ®Google Scholar
• . American Academy of Orthopaedic Surgeons. Treatment of Osteoarthritis of the Knee (Non-Arthroplasty). Rosemont, IL: American Academy of Orthopaedic Surgeons; December 6, 2008
   Google Scholar
• . Whelton A, Maurath CJ, Verburg KM, Geis GS. Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor. Am J Ther. 2000;7(3):159–175
   PubMedGoogle Scholar
• . White WB, West CR, Borer JS, . Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials. Am J Cardiol. 2007;99(1):91–98
   PubMed Web of Science ®Google Scholar